000 01559 a2200409 4500
005 20250513071121.0
264 0 _c19940217
008 199402s 0 0 eng d
022 _a0923-7534
024 7 _a10.1093/oxfordjournals.annonc.a058667
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan der Wall, E
245 0 0 _aFeasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cNov 1993
300 _a791-2 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aEpirubicin
_xadministration & dosage
650 0 4 _aErythrocyte Count
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPlatelet Count
700 1 _aRichel, D J
700 1 _aKusumanto, Y H
700 1 _aRutgers, E J
700 1 _aSchornagel, J H
700 1 _aSchaake-Koning, C C
700 1 _aPeterse, J L
700 1 _aRodenhuis, S
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 4
_gno. 9
_gp. 791-2
856 4 0 _uhttps://doi.org/10.1093/oxfordjournals.annonc.a058667
_zAvailable from publisher's website
999 _c8279943
_d8279943